Candid Health vs Revvity

Side-by-side comparison of AI visibility scores, market position, and capabilities

Revvity leads in AI visibility (94 vs 61)
Candid Health logo

Candid Health

ChallengerHealthcare

General

SF revenue cycle automation at $99.5M total ($52.5M Oak HC/FT Series C Feb 2025) growing 250% YoY in 2024; claim tracking and AI denial prevention competing with Waystar for digital health and multi-site provider group RCM automation.

AI VisibilityBeta
Overall Score
B61
Category Rank
#192 of 1158
AI Consensus
62%
Trend
down
Per Platform
ChatGPT
68
Perplexity
61
Gemini
56

About

Candid Health is a San Francisco-based revenue cycle automation platform — backed with $99.5 million in total funding including a $52.5 million Series C in February 2025 led by Oak HC/FT, following a $29 million Series B in September 2024 led by 8VC — providing healthcare providers with an end-to-end claims automation platform that tracks insurance claims through the full payer adjudication lifecycle, automatically detects and fixes claim errors before and after submission, and provides analytics that improve the touchless claim rate (the percentage of claims that process to payment without any human intervention). Candid Health grew revenue nearly 250% year-over-year in 2024 and is expanding from digital health startups (its initial market) to multi-site provider groups and health systems nationally.

Full profile
Revvity logo

Revvity

LeaderHealthcare Tech

Life Science Tools & Diagnostics

Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.

AI VisibilityBeta
Overall Score
A94
Category Rank
#1 of 1
AI Consensus
72%
Trend
up
Per Platform
ChatGPT
92
Perplexity
99
Gemini
96

About

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.

Full profile

AI Visibility Head-to-Head

61
Overall Score
94
#192
Category Rank
#1
62
AI Consensus
72
down
Trend
up
68
ChatGPT
92
61
Perplexity
99
56
Gemini
96
72
Claude
89
61
Grok
88

Key Details

Category
General
Life Science Tools & Diagnostics
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Revvity
Life Science Tools & Diagnostics

Integrations

Only Revvity
Revvity is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.